Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP enters the alveolar type II rare cell in the lung […]

Despite a storied career in drug design that has spanned multiple decades, James Woody believes there is still a significant amount of work left to be accomplished with the development of tumor necrosis factor (TNF) inhibitor biologics. “I’m excited about developing novel therapies for patients and I’m also excited about just discovering things,” Woody said […]

Tonix Pharmaceuticals Holding jumped as much as 24% early Wednesday, the latest in a group of tiny health-care stocks to get a boost in volume, after day traders touted the company on message boards for no apparent reason. Trading in micro-cap companies that most Wall Street professionals ignore has made up roughly 20% of all […]